ARTIDIS
ARTIDIS's nanomechanical sensor captures the physical properties of tissue enabling the clinician to differentiate between benign and malignant tissue in under three hours. In addition, the technology allows the clinician to define the aggressiveness of the tumor with very high accuracy based on the nanomechanical signature of the cells. Only very soft cells can squeeze through all different tissues to create distant metastases that are responsible for more than 90% of cancer related deaths. The nano-probe measures the tissue’s physical properties allowing us to discover robust nano-mechanical biomarkers and predict disease development. Moreover, ARTIDIS technology is not limited to cancer and can analyze any living tissue.
ARTIDIS
Industry:
Health Care Medical Device
Founded:
2017-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.artidis.com
Total Employee:
11+
Status:
Active
Contact:
+41 61 633 29 94
Total Funding:
39.7 M CHF
Technology used in webpage:
Domain Not Resolving Euro Amazon Nginx Apache Apple Mobile Web App Capable Apple Mobile Web App Status Bar Style Apache 2.4 Amazon Route 53 Ubuntu
Similar Organizations
Acorai
Acorai is a medical device manufacturer of non-invasive intracardiac pressure monitoring to improve heart failure management.
Healios AG
Healios AG is a MedTech company aiming to develop and validate digital biomarkers
Livance
Healthcare Infrastructure as a Service
P3 Health Partners
P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Selfapy
Selfapy offers a therapy support tool that helps recognize negative patterns of thought and train new behavior.
Sooma
Sooma Oy is developing a non-invasive brain stimulation device, a treatment option for depression and chronic pain. Mental health.
Strados Labs
Strados Labs innovates respiratory monitoring using smart biosensors and artificial intelligence.
TympaHealth
TympaHealth are a team of doctors and technology experts united in their vision of helping the world to hear.
WeWALK
WeWALK is a startup developing a smart cane for the visually-impaired.
Current Advisors List
Board_member
2018-01-01
Board_member
Current Employees Featured
Tobias Appenzeller Head, Clinical Operations & QMS, Co-Founder @ ARTIDIS
Head, Clinical Operations & QMS, Co-Founder
Marija Plodinec CEO & Co-Founder @ ARTIDIS
CEO & Co-Founder
2017-11-01
Philipp Oertle Co-Founder, CSO & CDO @ ARTIDIS
Co-Founder, CSO & CDO
Marko Loparic CMO @ ARTIDIS
CMO
Founder
Newest Events participated
Official Site Inspections
http://www.artidis.com Semrush global rank: 2.76 M Semrush visits lastest month: 6.28 K
- Host name: wl33.webland.ch
- IP address: 92.43.216.133
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "ARTIDIS"
ARTIDIS - Crunchbase Company Profile & Funding
ARTIDIS's nanomechanical sensor captures the physical properties of tissue enabling the clinician to differentiate between benign and malignant tissue in under three hours. In addition, …See details»
ARTIDIS - LinkedIn
ARTIDIS AG is a clinical stage medical technology company developing the first nanotechnology platform for tissue analysis combined with a digital data platform, intended for broad use in drug ...See details»
Leadership team and core values - ARTIDIS
Two, Artidis is made up of enormously talented and highly committed people who work as a team and empower each other to achieve the company’s purpose – it fun and motivating to be part …See details»
ARTIDIS AG – Swiss Biotech
ARTIDIS AG, based in Basel, Switzerland has developed a clinically validated, novel AI powered ARTIDIS tissue analysis device and software platform that harnesses the power of …See details»
ARTIDIS Company Profile 2024: Valuation, Funding & Investors
ARTIDIS was founded in 2014. Where is ARTIDIS headquartered? ARTIDIS is headquartered in Basel, Switzerland. What is the size of ARTIDIS? ARTIDIS has 73 total employees. What …See details»
Artidis AG | VentureRadar
ARTIDIS nanotechnology platform integrates different types of clinical data into the ARTIDISNet digital platform, allowing physicians to significantly shorten the current diagnostic process and …See details»
Former U.S. CDC Director joins Board of Swiss health technology …
Gerberding is President and CEO of the Foundation for the National Institutes of Health (FNIH), a non-profit organization based in the United States that builds public-private-patient biomedical …See details»
Artidis - Crunchbase Company Profile & Funding
Organization. Artidis . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Contact Email info@artidis.net; Phone Number 34 948 753 360; Lists Featuring This Company. Edit Lists …See details»
Artidis - Company Profile - Tracxn
Nov 16, 2024 Artidis ranks 111th among 487 active competitors. 159 of its competitors are funded while 96 have exited. Overall, Artidis and its competitors have raised over $10.2B in …See details»
ARTIDIS Company Profile - Office Locations, Competitors ... - Craft
Artidis is a medtech company that provides cancer diagnosis and optimized treatment decisions. The company develops innovative nanotechnologies in the healthcare field. It offers accurate …See details»
ARTIDIS - Contacts, Employees, Board Members, Advisors & Alumni
Organization. ARTIDIS . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board …See details»
ARTIDIS Launches Groundbreaking ANGEL Study With Over 2,700 ...
Nov 2, 2023 Houston, Texas, and Basel, Switzerland, November 2nd, 2023 – As Breast Cancer Awareness Month concludes, ARTIDIS announces the launch of its global multicenter clinical …See details»
Platform for nanomechanical tissue analysis | ARTIDIS
ARTIDIS ® is our nanomechanical sensor that captures the physical properties of tumor cells and their microenvironment, the stroma, with very high accuracy allowing us to develop robust …See details»
Artidis: Cancer diagnosis in less than 3 hours - HEMEX
Dec 17, 2018 Artidis AG, a spin-off from University of Basel founded by Dr. Plodinec and colleagues, seeks to build a distinctive and independent medtech company by pursuing the …See details»
ARTIDIS enters clinical collaboration to investigate …
Basel, Switzerland, May 4, 2021 – ARTIDIS AG, a privately held health-tech company, announces a collaboration with Hospital Clínic de Barcelona and the University of Barcelona to investigate ...See details»
Personalized diagnosis and treatment optimization - ARTIDIS
The use of ARTIDIS in healthcare enables the optimization of clinical workflows and minimizes over-treatment. How we change the status quo. Current cancer diagnosis is slow and …See details»
MD Anderson and ARTIDIS Announce Strategic Alliance to …
Oct 3, 2022 Collaboration aims to provide clinical validation of the ARTIDIS platform for broad cancer applicationsHOUSTON and BASEL, Switzerland, Oct. 03, 2022 (GLOBE NEWSWIRE) …See details»
ARTIDIS - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . May 31, 2023: Series A - …See details»
Career Opportunities | ARTIDIS is hiring
So do we at ARTIDIS. We are a passionate team of open-minded individuals driven by scientific curiosity, innovation, and the desire to make a positive impact for the patient and the …See details»